Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what studies have been undertaken on the (a) side effects of Gardasil used in the HPV Vaccination programme and (b) the long term effect of Gardasil on the health of girls and young women.

The Medicines and Healthcare products Regulatory Agency (MHRA), with advice from the Commission on Human Medicines, has closely evaluated the safety of the human papillomavirus (HPV) vaccine since the vaccination programme was first introduced in the United Kingdom in 2008 and since Gardasil has been in routine use from 2012. Extensive reviews of Gardasil vaccine safety have also been undertaken by other independent health bodies/authorities worldwide, including the European Medicines Agency, the United States Centers for Disease Control and Prevention and the World Health Organization. This continuous surveillance has found no evidence of serious harm or chronic illness caused by any HPV vaccine and is supported by published epidemiological studies from health authorities, including the MHRA and other independent academic researchers.